These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7579045)

  • 21. The legacy of Homer W. Smith: mechanistic insights into renal physiology.
    Navar LG
    J Clin Invest; 2004 Oct; 114(8):1048-50. PubMed ID: 15489950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophic cardiomyopathy and nephrogenic diabetes insipidus associated with chronic lithium carbonate use.
    Crocamo A; Demola P; Visioli F; Corradi D; Vignali L; Pelà G
    Psychiatry Res; 2020 Sep; 291():113153. PubMed ID: 32535507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent nephrogenic diabetes insipidus following lithium therapy.
    Thompson CJ; France AJ; Baylis PH
    Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal side effects of long-term lithium therapy].
    Ibbeken C; Becker JU; Baumgärtel MW
    Dtsch Med Wochenschr; 2012 Jan; 137(4):143-8. PubMed ID: 22259170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic renal complications induced by lithium].
    Le Roy V; Delmas Y; Verdoux H
    Encephale; 2009 Dec; 35(6):605-10. PubMed ID: 20004292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late onset nephrogenic diabetes insipidus following cessation of lithium therapy.
    Paw H; Slingo ME; Tinker M
    Anaesth Intensive Care; 2007 Apr; 35(2):278-80. PubMed ID: 17444321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.
    Meinardi JR; Donders SH
    Neth J Med; 1997 Mar; 50(3):105-9. PubMed ID: 9121593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unsuspected nephrogenic diabetes insipidus.
    Waise A; Fisken RA
    BMJ; 2001 Jul; 323(7304):96-7. PubMed ID: 11451787
    [No Abstract]   [Full Text] [Related]  

  • 30. [Impaired kidney function in lithium therapy].
    Gabutti L; Gugger M; Marti HP
    Ther Umsch; 1998 Sep; 55(9):562-4. PubMed ID: 9789472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nephrogenic diabetes insipidus during lithium acute intoxication].
    Abodo J; Seux V; Koffi-Dago P; Dalco O; Renaud-Lévy O; Tassy S; Million M; Lokrou A; Soubeyrand J; Retornaz F
    Ann Endocrinol (Paris); 2007 Dec; 68(6):467-9. PubMed ID: 18031708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium-Induced Nephropathy.
    Pawar AS; Kattah AG
    N Engl J Med; 2018 Mar; 378(11):1042. PubMed ID: 29539276
    [No Abstract]   [Full Text] [Related]  

  • 33. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Karimi Z
    Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
    Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
    BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Water, lithium and sodium: watch out for dangerous injuries].
    Fayolle M; Souweine JS; Mathieu O; Bargnoux AS; Cristol JP; Badiou S
    Ann Biol Clin (Paris); 2020 Aug; 78(4):449-453. PubMed ID: 32618565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contribution of Japanese researchers to progress in studies on nephrology in the past 100 years: Molecular cloning of water channels in the kidney collecting duct and the etiology of nephrogenic diabetes insipidus].
    Sasaki S
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1437-9. PubMed ID: 12082731
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal concentrating ability and glomerular filtration rate in lithium-treated patients.
    Doornebal J; Diepenbroek A; van de Luijtgaarden MWM; Hartong EGTM; Grootens KP; Kupka RW; Klumpers UMH; Deen PMT; Gaillard CA; Wetzels JFM
    Neth J Med; 2019 May; 77(4):139-149. PubMed ID: 31502545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical hyponatremia and polyurodipsia in a patient with lithium-induced nephrogenic diabetes insipidus.
    Fasanello RA; Vu TM
    J Am Osteopath Assoc; 2012 Sep; 112(9):588. PubMed ID: 22984230
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful rescue of severe hypernatraemia (196 mmol/L) by treatment with hypotonic fluid.
    Jeffery J; Ayling RM; McGonigle RJ
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):491-4. PubMed ID: 17761039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium carbonate-induced nephrogenic diabetes insipidus and glucose intolerance.
    Martinez-Maldonado M; Terrell J
    Arch Intern Med; 1973 Dec; 132(6):881-4. PubMed ID: 4757260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.